insights_auto
Why is MOLBIO up 4.08%?
Dive Deeperchevron_right
MOLBIO:NSE
Molbio Diagnostics Limited
₹1,315.30
arrow_upward
+4.08%(+51.50) 1D
Sep 23, 10:14:37 AM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLBIO...
Open
₹1,274.70
High
₹1,336.90
Low
₹1,260.20
Mkt. cap
151.59B
Avg. vol.
3.95M
Volume
847.97K
P/E ratio
89.03
52-wk high
₹1,686.80
52-wk low
₹926.35
EPS
₹14.77
No. of employees
1K
Open
₹1,274.70
High
₹1,336.90
Low
₹1,260.20
Mkt. cap
151.59B
Avg. vol.
3.95M
Volume
847.97K
P/E ratio
89.03
52-wk high
₹1,686.80
52-wk low
₹926.35
EPS
₹14.77
No. of employees
1K
Profile
Molbio Diagnostics Limited is an Indian medical diagnostics company headquartered in Verna, Goa, that develops molecular diagnostic technologies. Founded in 2000, the company developed the Truenat platform, a portable real-time PCR system used to diagnose infectious diseases including tuberculosis, HIV, and hepatitis.
The Truenat platform is recognized by the World Health Organization for the initial detection of tuberculosis and rifampicin resistance. Following clinical studies, including research published in The Lancet, the technology has been adopted by national health programs in over 85 countries.
In 2025, Molbio was awarded the Kochon Prize by the Stop TB Partnership, the world's largest award for tuberculosis. Wikipedia
About Molbio Diagnostics Limited